International Psoriasis Council

International Psoriasis Council
subscribe
5   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Welcoming IPC’s Newest Councilors: Advancing Global Psoriasis Care Through Expert Leadership

Join us in welcoming IPC’s newest Councilors: Jaquelini Barboza da Silva, Mona El-Kalioby, Yayoi Tada, Emi Nishida, and Lisa Zhenying Zhang. Recently appointed by the IPC Board of Directors, these accomplished experts bring diverse perspectives and deep commitment to advancing psoriasis research and improving care for patients around the world.

In their roles as IPC Councilors, they will actively support our global initiatives in research, treatment, and education—helping to elevate standards of care and empower clinicians worldwide.

We invite you to explore their bios and see how their work is shaping the future of psoriasis care. Please join us in welcoming these outstanding leaders as they begin their journey as IPC Councilors.

Jaquelini Barboza da Silva, MD

Santa Cruz University

Santa Cruz do Sul, Brazil

IPC Councilor

Bio

Mona El-Kalioby, MBBCh, MSc, MD

Kasr Al-Ainy Hospital, Cairo University

Cairo, Egypt

IPC Councilor

Bio

Yayoi Tada, MD, PhD

Teikyo University School of Medicine

Tokyo, Japan

IPC Councilor

Bio

Emi Nishida, MD, PhD

Nagoya City University West Medical Center

Nagoya, Japan

IPC Councilor

Bio

Lisa Zhenying Zhang, MD, PhD

University of Hong Kong-Shenzhen Hospital

Shenzhen, China

IPC Councilor

Bio

Categories

Recent Posts

Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors

VIEW

Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic Advances, and Emerging Research

VIEW
A man in a suit smiles at the camera next to text that reads, World Psoriasis Experts Give Their Take on Current, Hot, or Controversial Topics like Biologics in Psoriasis Management. EXPERT COMMENTARY.

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

VIEW

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.
Subscribe

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »
Monday, April 27, 2026

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026